Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.3300 (-3.17%) ($7.1600 - $7.5400) on Fri. May. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.22% (three month average) | RSI | 49 | Latest Price | $7.3300(-3.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.9% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UUP(7%) XLC(4%) BLOK(2%) TBT(2%) VXX(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.61% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.61% (StdDev 3.22%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $7.75 | 5 Day Moving Average | $7.65(-4.18%) | 10 Day Moving Average | $7.77(-5.66%) | 20 Day Moving Average | $7.75(-5.42%) | To recent high | -19.9% | To recent low | 0.7% | Market Cap | $1.293b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |